Differences in Coagulation Test Kits
NCT01109667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2010-04-23
Summary
The aim of this study is to assess the effect of Innovin® reagent on laboratory results when compared with the Thromborel® S.
Conditions
- Effect of Different Reagents.
- Oral Anticoagulant Therapy
Sponsors & Collaborators
-
Yuksek Ihtisas Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
NCT06269302 ·Status: COMPLETED
-
Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382
NCT03347968 ·Status: COMPLETED ·Phase: PHASE1
-
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study
NCT03292666 ·Status: COMPLETED
-
Comparison Study of CoaguChek XS PT and Laboratory Innovin PT by NTUH Lab Medicine
NCT00867646 ·Status: COMPLETED
-
Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer
NCT03180567 ·Status: UNKNOWN ·Phase: NA
-
The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
NCT05006287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Recanalization Rate of Acute DVT
NCT06145269 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
NCT06355258 ·Status: RECRUITING ·Phase: PHASE1
-
Safer Warfarin Treatment
NCT01042067 ·Status: SUSPENDED
-
The Affect Of An Anti-Embolism Stocking Protocol
NCT06616376 ·Status: COMPLETED ·Phase: NA
-
Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture
NCT02207205 ·Status: COMPLETED ·Phase: NA
-
A Study of MK-2060 in Healthy Participants (MK-2060-016)
NCT06582602 ·Status: COMPLETED ·Phase: PHASE1
-
Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
NCT02892565 ·Status: COMPLETED ·Phase: NA
-
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
NCT01130025 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography
NCT02448901 ·Status: UNKNOWN
-
Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation
NCT05205863 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Quantra QPlus Sample Type Comparison
NCT05290675 ·Status: COMPLETED
-
Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome
NCT02562690 ·Status: UNKNOWN
-
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.
NCT05333666 ·Status: RECRUITING
-
Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants
NCT03296982 ·Status: COMPLETED
-
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
NCT03161496 ·Status: UNKNOWN
-
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005684 ·Status: COMPLETED
-
Prophylactic Anticoagulation for Catheter-related Thrombosis
NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Trial of a Validated Algorithm for Warfarin Dosing
NCT02705976 ·Status: COMPLETED ·Phase: NA